These structures have been shown to form due to high levels of HMG-CoA reductase, a key enzyme in the cholesterol biosynthesis pathway, central to the lipid reprogramming that occurs during PCa progression (35, 36). The gene discussed is HMGCR; the disease is posterior cortical atrophy.